Cosmo Pharmaceuticals N.V Strategic Asset Allocation Index
Cosmo Pharmaceuticals N.V strategic asset allocation index. Cosmo Pharmaceuticals N.V (C43) has a Strategic Asset Allocation Index of 6.5% as of June 2022. Strategic assets (PP&E of €30.40 Million plus long-term investments of €-) total €30.40 Million, measured against net assets of €469.22 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See C43 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cosmo Pharmaceuticals N.V (2016–2021)
Strategic asset allocation index of Cosmo Pharmaceuticals N.V from 2016 to 2021. This chart shows how Cosmo Pharmaceuticals N.V's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2022, the index stands at 6.5%, representing strategic assets of €30.40 Million against net assets of €469.22 Million EUR. Check how tangible is Cosmo Pharmaceuticals N.V's equity to evaluate the tangible quality of the company's equity base.
Cosmo Pharmaceuticals N.V Strategic Asset Allocation Index by Year (2016–2021)
Cosmo Pharmaceuticals N.V strategic asset allocation index by year from 2016 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Cosmo Pharmaceuticals N.V from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Cosmo Pharmaceuticals N.V (C43) market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 5.9% | €30.48 Million | €30.48 Million | €- | €512.68 Million | ▼ -1.4 pp |
| 2020 | 7.3% | €29.30 Million | €29.30 Million | €- | €400.12 Million | ▼ -0.3 pp |
| 2019 | 7.7% | €30.19 Million | €30.19 Million | €- | €393.73 Million | ▲ +1.2 pp |
| 2018 | 6.4% | €28.62 Million | €28.62 Million | €- | €444.85 Million | ▲ +0.0 pp |
| 2017 | 6.4% | €30.15 Million | €30.15 Million | €- | €470.12 Million | ▲ +1.4 pp |
| 2016 | 5.0% | €20.67 Million | €20.67 Million | €- | €415.56 Million | — |